233 related articles for article (PubMed ID: 16521437)
1. [Monoclonal antibodies in dermatological practice].
Rudnicka L; Szymańska E; Oledzka E; Olszewska M
Pol Merkur Lekarski; 2005 Dec; 19(114):839-42. PubMed ID: 16521437
[TBL] [Abstract][Full Text] [Related]
2. [Biologics in skin diseases other than psoriasis].
Gniadecki R; Skov L
Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
[TBL] [Abstract][Full Text] [Related]
3. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).
Graves JE; Nunley K; Heffernan MP
J Am Acad Dermatol; 2007 Jan; 56(1):e55-79. PubMed ID: 17190618
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept.
Weinberg JM; Bottino CJ; Lindholm J; Buchholz R
J Drugs Dermatol; 2005; 4(5):544-55. PubMed ID: 16167412
[TBL] [Abstract][Full Text] [Related]
5. Biologicals in the treatment of psoriasis.
Boker A; Kimball AB; Rolz-Cruz G
Curr Opin Investig Drugs; 2007 Nov; 8(11):939-46. PubMed ID: 17979028
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients.
Brunasso AM; Puntoni M; Salvini C; Delfino C; Curcic P; Gulia A; Massone C
Acta Derm Venereol; 2011 Jan; 91(1):44-9. PubMed ID: 21088813
[TBL] [Abstract][Full Text] [Related]
7. [New systemic treatments for psoriasis: etanercept, infliximab, adalimumab, efalizumab and alefacept].
Bos WE; Thio HB; Neumann HA; van der Fits L; Prens EP
Ned Tijdschr Geneeskd; 2006 May; 150(19):1065-70. PubMed ID: 16733982
[TBL] [Abstract][Full Text] [Related]
8. Biological agents in the treatment of psoriasis.
Tzu J; Krulig E; Cardenas V; Kerdel FA
G Ital Dermatol Venereol; 2008 Oct; 143(5):315-27. PubMed ID: 18833073
[TBL] [Abstract][Full Text] [Related]
9. Experience with biologics for psoriasis in daily practice: switching is worth a try.
Lecluse LL; de Groot M; Bos JD; Spuls PI
Br J Dermatol; 2009 Oct; 161(4):948-51. PubMed ID: 19663876
[No Abstract] [Full Text] [Related]
10. Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus.
Saini R; Tutrone WD; Weinberg JM
Curr Pharm Des; 2005; 11(2):273-80. PubMed ID: 15638763
[TBL] [Abstract][Full Text] [Related]
11. [Biologics in the treatment of psoriasis].
Dissemond J; Grabbe S
MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
[TBL] [Abstract][Full Text] [Related]
12. [Anti-cytokine therapy for connective tissue disease].
Hayashi T; Goto D; Sumida T
Nihon Rinsho; 2005 May; 63 Suppl 5():233-9. PubMed ID: 15954355
[No Abstract] [Full Text] [Related]
13. Tumor necrosis factor inhibitors in psoriasis: an update.
Kerdel FA; Strober BE
Semin Cutan Med Surg; 2014 Mar; 33(2 Suppl 2):S31-6. PubMed ID: 24979543
[TBL] [Abstract][Full Text] [Related]
14. [Biological treatment of psoriasis and psoriatic arthritis].
Kragballe K; Deleuran B
Ugeskr Laeger; 2008 Jun; 170(24):2148-50. PubMed ID: 18565300
[TBL] [Abstract][Full Text] [Related]
15. Erythrodermic psoriasis: current and future role of biologicals.
Stinco G; Errichetti E
BioDrugs; 2015 Apr; 29(2):91-101. PubMed ID: 25752640
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapies in psoriasis: a new therapeutic approach.
Gisondi P; Girolomoni G
Autoimmun Rev; 2007 Sep; 6(8):515-9. PubMed ID: 17854741
[TBL] [Abstract][Full Text] [Related]
17. [Biologic therapies in the treatment of psoriasis].
Farhi D; Dupin N
Presse Med; 2009 May; 38(5):832-43. PubMed ID: 19282134
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab vs. etanercept in psoriasis.
Downs AM
Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
[No Abstract] [Full Text] [Related]
19. Therapeutic monoclonal antibodies in ophthalmology.
Rodrigues EB; Farah ME; Maia M; Penha FM; Regatieri C; Melo GB; Pinheiro MM; Zanetti CR
Prog Retin Eye Res; 2009 Mar; 28(2):117-44. PubMed ID: 19114125
[TBL] [Abstract][Full Text] [Related]
20. [Biological treatment options for Graves' ophthalmopathy].
El Fassi D; Nielsen CH; Hegedüs L
Ugeskr Laeger; 2008 Jun; 170(24):2128-30. PubMed ID: 18565294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]